GL1X · GenesisL1 explorer

Research workbench

Crystal structure of SARS-cov-2 3CLPRO in complex with the non- covalent inhibitor wu-04

Analyse Crystal structure of SARS-cov-2 3CLPRO in complex with the non- covalent… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
7EN8
Type
protein
Length
607 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
3C-like proteinase
EC
3.4.22.69
UniProt
P0DTC1
Ligands
J7R
Pockets
7 · best druggability 0.75

Structure

x-ray diffraction · 2 distinct chains · 26% helix, 29% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
A3C-like proteinase (EC 3.4.22.69)protein30626% helix, 29% strandP0DTC1
B3C-like proteinase (EC 3.4.22.69)protein30126% helix, 30% strandP0DTC1

Ligands and binding sites

  • J7R · ~{N}-[(1~{S},2~{R})-2-[[4-bromanyl-2-(methylcarbamoyl)-6-nitro-phenyl]amino]cyclohexyl]isoquinoline-4-carboxamide · ligand · 2 copies · chains A, B
  • GOL · Glycerol · additive · chains B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

7 pockets found on a 1 Å grid, 2 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
19790.750.7880empty
24390.570.7457empty
32010.490.7629J7R
41880.440.7427J7R
51530.420.7425empty

Interfaces

1 interface between chains.

  • A–B · 1492 Ų buried · 44 hydrogen bonds · protein-protein

Compared structures

  • 7EN8 · Crystal structure of SARS-CoV-2 3CLpro in complex with the non-covalent inhibitor WU-04 · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.